Suppr超能文献

IV 期结直肠癌的预后评分系统:AJCC IV 期结直肠癌的亚分类合适吗?

Prognostic scoring system for stage IV colorectal cancer: is the AJCC sub-classification of stage IV colorectal cancer appropriate?

机构信息

Center for Minimally Invasive Surgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.

出版信息

Int J Clin Oncol. 2013 Aug;18(4):696-703. doi: 10.1007/s10147-012-0433-5. Epub 2012 Jun 13.

Abstract

BACKGROUND

Stage IV colorectal cancer encompasses various clinical conditions. The aim of this study was to validate the utility of the recent AJCC stage IV colorectal cancer sub-classification, and to establish a prognostic scoring system using independent factors.

METHODS

We conducted a retrospective analysis using data from the multicenter registry. Factors affecting the curative resection and prognosis were analyzed in patients with stage IV colorectal cancer.

RESULTS

Of the 60,176 patients who received surgery for colorectal cancer, 9,624 (16.0 %) were classified as stage IV. The prognoses of patients with peritoneum-only metastasis were superior to those of patients with a stage IVB (P < 0.0001). Of the 11 independent prognostic factors identified, eight with a hazard ratio greater than 1.3 (depth of tumor invasion, regional lymph node metastasis, histologic grade, liver metastasis, lung metastasis, distant lymph node metastasis, peritoneal metastasis, and curative resection) were used in the prognostic scoring system. The scoring system gave one or two points for the presence of each prognosis risk factor, resulting in a total score ranging from 0 to 9. The 5-year overall survival rates of patients with a total score of 0-2, 3, 4, 5, and 6-9 were 50.4, 30.4, 17.7, 7.7, and 4.0 %, respectively (P < 0.0001).

CONCLUSION

Although the AJCC staging for patients with stage IV colorectal cancer reflected the prognosis, patients with peritoneum-only metastases should be classified as stage IVA. The prognostic scoring system using eight independent factors is useful in predicting the survival of patients with stage IV colorectal cancer.

摘要

背景

IV 期结直肠癌包含多种临床情况。本研究旨在验证 AJCC 最近提出的 IV 期结直肠癌亚分类的实用性,并建立使用独立因素的预后评分系统。

方法

我们使用多中心登记处的数据进行了回顾性分析。分析了 IV 期结直肠癌患者中影响根治性切除和预后的因素。

结果

在接受结直肠癌手术的 60176 例患者中,9624 例(16.0%)被归类为 IV 期。仅有腹膜转移的患者预后优于 IVB 期患者(P<0.0001)。在确定的 11 个独立预后因素中,有 8 个风险比大于 1.3(肿瘤浸润深度、区域淋巴结转移、组织学分级、肝转移、肺转移、远处淋巴结转移、腹膜转移和根治性切除)被用于预后评分系统。评分系统为每个预后危险因素的存在赋予 1 分或 2 分,总分为 0 至 9 分。总分为 0-2、3、4、5 和 6-9 的患者 5 年总生存率分别为 50.4%、30.4%、17.7%、7.7%和 4.0%(P<0.0001)。

结论

尽管 AJCC 分期反映了 IV 期结直肠癌患者的预后,但仅有腹膜转移的患者应归类为 IVA 期。使用 8 个独立因素的预后评分系统有助于预测 IV 期结直肠癌患者的生存情况。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验